PTC Therapeutics (PTCT) P/E (2013 - 2026)
PTC Therapeutics (PTCT) P/E from Jul 1, 2013 to Jul 21, 2026. The TTM PTC Therapeutics (PTCT) P/E is -34.01. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of PTC Therapeutics (PTCT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -34.01 | -487.84% |
| 2025 | 8.77 | -191.65% |
| 2024 | -9.57 | +199.15% |
| 2023 | -3.20 | -37.60% |
| 2022 | -5.13 | -4.54% |
| 2021 | -5.37 | -54.75% |
| 2020 | -11.86 | +3.43% |
| 2019 | -11.47 | -12.09% |
| 2018 | -13.05 | +124.36% |
| 2017 | -5.82 | +160.60% |
| 2016 | -2.23 | -65.28% |
| 2015 | -6.43 | -61.59% |
| 2014 | -16.73 | +52.85% |
| 2013 | -10.95 | N/A |
Comparison PTC Therapeutics (PTCT) P/E with competitors
PTC Therapeutics (PTCT) P/E is -34.01.